NewGenIvf Group Limited
NIVF
$1.80
$0.052.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.27M | 1.47M | 1.34M | 1.34M | 1.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.27M | 1.47M | 1.34M | 1.34M | 1.52M |
| Cost of Revenue | 734.50K | 824.00K | 1.02M | 1.02M | 1.32M |
| Gross Profit | 539.10K | 648.80K | 319.50K | 319.50K | 196.80K |
| SG&A Expenses | 1.63M | 432.50K | 463.30K | 463.30K | -35.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.36M | 1.26M | 1.49M | 1.49M | 1.29M |
| Operating Income | -1.09M | 216.30K | -143.80K | -143.80K | 232.80K |
| Income Before Tax | -542.70K | -30.30K | -193.90K | -193.90K | 295.60K |
| Income Tax Expenses | -486.70K | -- | -- | -- | -83.70K |
| Earnings from Continuing Operations | -56.00K | -30.30K | -193.90K | -193.90K | 379.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -52.30K | 10.50K | -4.40K | -4.40K | -43.70K |
| Net Income | -108.20K | -19.90K | -198.30K | -198.30K | 335.60K |
| EBIT | -1.09M | 216.30K | -143.80K | -143.80K | 232.80K |
| EBITDA | -1.09M | 223.00K | -137.50K | -137.50K | 258.10K |
| EPS Basic | -3.73 | -1.96 | -19.54 | -19.54 | 14.72 |
| Normalized Basic EPS | -13.49 | -0.84 | -12.37 | -12.37 | 6.19 |
| EPS Diluted | -3.73 | -1.96 | -19.54 | -19.54 | 14.69 |
| Normalized Diluted EPS | -13.49 | -0.84 | -12.37 | -12.37 | 6.19 |
| Average Basic Shares Outstanding | 29.00K | 10.10K | 10.10K | 10.10K | 22.80K |
| Average Diluted Shares Outstanding | 29.00K | 10.10K | 10.10K | 10.10K | 22.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |